Keith Marmer is CEO of Baerenkraft Therapeutics, where he leads efforts to bring new treatments to patients in need. He has more than 35 years’ experience as an entrepreneur, executive, and investor. Keith has co-founded two venture funds, including UVB Capital, a Utah-based venture fund focused on early-stage life science companies.  Over the course of his career, Keith has supported the launch of more than 300 startups and facilitated more than 700 licensing and M&A transactions. When he is not working with or investing in companies, you can find Keith skiing, hiking, cooking and spending time with family.